bexagliflozin

Generic: bexagliflozin

Labeler: golden state medical supply, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name bexagliflozin
Generic Name bexagliflozin
Labeler golden state medical supply, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

bexagliflozin 20 mg/1

Manufacturer
Golden State Medical Supply, Inc.

Identifiers & Regulatory

Product NDC 51407-918
Product ID 51407-918_32d96cd2-becc-1822-e063-6394a90a4217
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA214373
Listing Expiration 2026-12-31
Marketing Start 2023-01-20

Pharmacologic Class

Established (EPC)
sodium-glucose cotransporter 2 inhibitor [epc]
Mechanism of Action
sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51407918
Hyphenated Format 51407-918

Supplemental Identifiers

RxCUI
2637859
UNII
EY00JF42FV
NUI
N0000187059 N0000187058

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bexagliflozin (source: ndc)
Generic Name bexagliflozin (source: ndc)
Application Number NDA214373 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (51407-918-30)
  • 90 TABLET in 1 BOTTLE (51407-918-90)
source: ndc

Packages (2)

Ingredients (1)

bexagliflozin (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "32d96cd2-becc-1822-e063-6394a90a4217", "openfda": {"nui": ["N0000187059", "N0000187058"], "unii": ["EY00JF42FV"], "rxcui": ["2637859"], "spl_set_id": ["1a3ba9d5-1009-bad0-e063-6294a90ac4cc"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (51407-918-30)", "package_ndc": "51407-918-30", "marketing_start_date": "20240606"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (51407-918-90)", "package_ndc": "51407-918-90", "marketing_start_date": "20240606"}], "brand_name": "Bexagliflozin", "product_id": "51407-918_32d96cd2-becc-1822-e063-6394a90a4217", "dosage_form": "TABLET", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "51407-918", "generic_name": "Bexagliflozin", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bexagliflozin", "active_ingredients": [{"name": "BEXAGLIFLOZIN", "strength": "20 mg/1"}], "application_number": "NDA214373", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20230120", "listing_expiration_date": "20261231"}